UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis

Cancers, 2019-11, Vol.11 (11), p.1723

2019

Volltextzugriff (PDF)

The use of prognostic factors in metastatic renal cell carcinoma

Urologic oncology, 2015-12, Vol.33 (12), p.509-516

2015

Volltextzugriff (PDF)

Sex Disparities in Outcomes of Early Stage Colorectal Cancer: A Population-Based Study

Clinical colorectal cancer, 2018-12, Vol.17 (4), p.e711-e717

2018

Volltextzugriff (PDF)

Updates in the management of intradural spinal cord tumors: a radiation oncology focus

Neuro-oncology (Charlottesville, Va.), 2019-06, Vol.21 (6), p.707-718

2019

Volltextzugriff (PDF)

Primary Care Versus Oncology-Based Surveillance Following Adjuvant Chemotherapy in Resected Pancreatic Cancer

Journal of gastrointestinal cancer, 2018-12, Vol.49 (4), p.429-436

2018

Volltextzugriff (PDF)

Effectiveness and components of self-management interventions in adult cancer survivors: a protocol for a systematic review and planned meta-analysis

Systematic reviews, 2018-12, Vol.7 (1), p.238-238, Article 238

2018

Volltextzugriff (PDF)

Evaluation of Adjuvant Chemotherapy-Associated Steatosis (CAS) in Colorectal Cancer

Current oncology (Toronto), 2021-08, Vol.28 (4), p.3030-3040

2021

Volltextzugriff (PDF)

Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian database

Cancer medicine (Malden, MA), 2018-07, Vol.7 (7), p.2816-2825

2018

Volltextzugriff (PDF)

Second‐line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real‐world eligibility for cabozantinib, regorafenib, and ramucirumab

Cancer medicine (Malden, MA), 2020-07, Vol.9 (13), p.4640-4647

2020

Volltextzugriff (PDF)

Adjuvant therapy use and outcomes of stage II and III colorectal cancer (CRC): Comparison of young and elderly patients (pts) in a large, contemporary, population-based Canadian database

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.807-807

2018

Volltextzugriff (PDF)

Primary care vs. oncology-driven surveillance following adjuvant chemotherapy in resected pancreas cancer

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.421-421

2017

Volltextzugriff (PDF)

Patterns of unavoidable and potentially avoidable hospitalizations among cancer patients

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e18030-e18030

2017

Volltextzugriff (PDF)

Real-world use of trifluridine/tipiracil for patients with metastatic colorectal cancer in Canada

Current oncology (Toronto), 2019-10, Vol.26 (5), p.319-329

2019

Volltextzugriff (PDF)

Primary care vs. oncology-driven surveillance following adjuvant chemotherapy in resected pancreas cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e18163-e18163

2017

Volltextzugriff (PDF)

Comparing characteristics and outcomes of cancer to non-cancer patients admitted to general internal medicine (GIM)

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.21-21

2020

Volltextzugriff (PDF)

A real-world comparison of multi-modality therapies in locally advanced gastro-esophageal junction (GEJ) cancers

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.96-96

2018

Volltextzugriff (PDF)

Relationship between ethnicity and overall survival (OS) in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S)

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.248-248

2018

Volltextzugriff (PDF)

Risk and predictors of suicide in colorectal cancer patients: a Surveillance, Epidemiology, and End Results analysis

Current oncology (Toronto), 2017-12, Vol.24 (6), p.e513-517

2017

Volltextzugriff (PDF)

Treatment of hepatocellular carcinoma (HCC) after sorafenib (S) over the last 10 years

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.438-438

2019

Volltextzugriff (PDF)

Real world eligibility for cabozantinib (C), regorafenib (Reg), and ramucirumab (Ram) in hepatocellular carcinoma (HCC) patients after sorafenib (S)

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.422-422

2019

Volltextzugriff (PDF)

The impact of admitting ward on resource utilization and outcomes among hospitalized cancer survivors

JCO oncology practice, 2024-10, Vol.20 (10_suppl), p.36-36

2024

Volltextzugriff (PDF)

Comparison of prognostic models for hepatocellular carcinoma (HCC) in patients treated with the sorafenib: Results from a Canadian multi-center HCC database

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e15653-e15653

2017

Volltextzugriff (PDF)

Effect of sorafenib (S) starting dose and dose intensity on survival in patients with hepatocellular carcinoma (HCC): Results from a Canadian multicenter HCC database

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4084-4084

2017

Volltextzugriff (PDF)

Risk and predictors of suicide in colorectal cancer patients: A SEER analysis

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.9596-9596

2013

Volltextzugriff (PDF)

Victims of Our Own Success: Cardiac Toxicities from Conventional and Emerging Cancer Therapies

The MASCC Textbook of Cancer Supportive Care and Survivorship, p.165-179

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(25)
Buchkapitel
(1)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis

The use of prognostic factors in metastatic renal cell carcinoma

Sex Disparities in Outcomes of Early Stage Colorectal Cancer: A Population-Based Study

Updates in the management of intradural spinal cord tumors: a radiation oncology focus

Primary Care Versus Oncology-Based Surveillance Following Adjuvant Chemotherapy in Resected Pancreatic Cancer

Effectiveness and components of self-management interventions in adult cancer survivors: a protocol for a systematic review and planned meta-analysis

Evaluation of Adjuvant Chemotherapy-Associated Steatosis (CAS) in Colorectal Cancer

Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian database

Second‐line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real‐world eligibility for cabozantinib, regorafenib, and ramucirumab

Adjuvant therapy use and outcomes of stage II and III colorectal cancer (CRC): Comparison of young and elderly patients (pts) in a large, contemporary, population-based Canadian database

Primary care vs. oncology-driven surveillance following adjuvant chemotherapy in resected pancreas cancer

Patterns of unavoidable and potentially avoidable hospitalizations among cancer patients

Real-world use of trifluridine/tipiracil for patients with metastatic colorectal cancer in Canada

Primary care vs. oncology-driven surveillance following adjuvant chemotherapy in resected pancreas cancer

Comparing characteristics and outcomes of cancer to non-cancer patients admitted to general internal medicine (GIM)

A real-world comparison of multi-modality therapies in locally advanced gastro-esophageal junction (GEJ) cancers

Relationship between ethnicity and overall survival (OS) in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S)

Risk and predictors of suicide in colorectal cancer patients: a Surveillance, Epidemiology, and End Results analysis

Treatment of hepatocellular carcinoma (HCC) after sorafenib (S) over the last 10 years

Real world eligibility for cabozantinib (C), regorafenib (Reg), and ramucirumab (Ram) in hepatocellular carcinoma (HCC) patients after sorafenib (S)

The impact of admitting ward on resource utilization and outcomes among hospitalized cancer survivors

Comparison of prognostic models for hepatocellular carcinoma (HCC) in patients treated with the sorafenib: Results from a Canadian multi-center HCC database

Effect of sorafenib (S) starting dose and dose intensity on survival in patients with hepatocellular carcinoma (HCC): Results from a Canadian multicenter HCC database

Risk and predictors of suicide in colorectal cancer patients: A SEER analysis

Victims of Our Own Success: Cardiac Toxicities from Conventional and Emerging Cancer Therapies

Suchergebnisse filtern